1.
Fusco R,
Sansone M,
Petrillo M,
Setola SV,
Granata V,
Botti G,
et al.
Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging,
diffusion-weighted imaging and spectroscopy imaging.
Magn Reson Imaging.
Elsevier; 2016 Sep;34(7):839–45.
2.
Kurhanewicz J,
Vigneron D,
Carroll P,
Coakley F.
Multiparametric magnetic resonance imaging in prostate cancer: present and future.
Current opinion in urology.
NIH Public Access; 2007 Dec 31;18(1):71–7.
3.
Donati OF,
Mazaheri Y,
Afaq A,
Vargas HA,
Zheng J,
Moskowitz CS,
et al.
Prostate Cancer Aggressiveness: Assessment with Whole-Lesion Histogram Analysis of the Apparent Diffusion Coefficient.
Radiology.
Radiological Society of North America; 2013 Dec 12;271(1):143–52.
4.
Donati OF,
Afaq A,
Vargas HA,
Mazaheri Y,
Zheng J,
Moskowitz CS,
et al.
Prostate MRI: Evaluating Tumor Volume and Apparent Diffusion Coefficient as Surrogate Biomarkers for Predicting Tumor Gleason Score.
Clin Cancer Res.
American Association for Cancer Research; 2014 Jul 15;20(14):3705–11.
5.
Wu C-J,
Wang Q,
Li H,
Wang X-N,
Liu X-S,
Shi H-B,
et al.
DWI-associated entire-tumor histogram analysis for the differentiation of low-grade prostate cancer from intermediate–high-grade prostate cancer.
Abdom Imaging.
Springer US; 2015;40(8):3214–21.
6.
Costa DN,
Bloch BN,
Yao DF,
Sanda MG,
Ngo L,
Genega EM,
et al.
Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies.
Magn Reson Imaging.
2013 Jul;31(6):947–52.
7.
Cornud F,
Brolis L,
Delongchamps NB,
Portalez D,
Malavaud B,
Renard-Penna R,
et al.
TRUS–MRI image registration: a paradigm shift in the diagnosis of significant prostate cancer.
Abdom Imaging.
Springer US; 2013;38(6):1447–63.
8.
Hoeks CMA,
Somford DM,
van Oort IM,
Vergunst H,
Oddens JR,
Smits GA,
et al.
Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.
Invest Radiol.
2014 Mar;49(3):165–72.
9.
Ahmed HU,
El-Shater Bosaily A,
Brown LC,
Gabe R,
Kaplan R,
Parmar MK,
et al.
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Lancet.
Elsevier; 2017 Feb 25;389(10071):815–22.
10.
Weinreb JC,
Barentsz JO,
Choyke PL,
Cornud F,
Haider MA,
Macura KJ,
et al.
PI-RADS Prostate Imaging - Reporting and Data System: 2015,
Version 2.
Eur Urol.
Elsevier; 2016 Jan;69(1):16–40.
11.
Barth BK,
Cornelius A,
Nanz D,
Eberli D,
Donati OF.
Comparison of image quality and patient discomfort in prostate MRI: pelvic phased array coil vs.
endorectal coil.
Abdom Radiol (NY).
Springer US; 2016 Nov;41(11):2218–26.
12.
Turkbey B,
Merino MJ,
Gallardo EC,
Shah V,
Aras O,
Bernardo M,
et al.
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology.
J Magn Reson Imaging.
2014 Jun;39(6):1443–8.
13.
Barentsz JO,
Richenberg J,
Clements R,
Choyke P,
Verma S,
Villeirs G,
et al.
ESUR prostate MR guidelines 2012.
Vol.
22,
European radiology.
Springer-Verlag; 2012.
pp.
746–57.
14.
Shah ZK,
Elias SN,
Abaza R,
Zynger DL,
DeRenne LA,
et al.
Performance Comparison of 1.5-T Endorectal Coil MRI with 3.0-T Nonendorectal Coil MRI in Patients with Prostate Cancer.
Acad Radiol.
Elsevier Ltd; 2015 Apr 1;22(4):467–74.
15.
Sosna J,
Pedrosa I,
Dewolf WC,
Mahallati H,
Lenkinski RE,
Rofsky NM.
MR imaging of the prostate at 3 tesla.
Acad Radiol.
2004 Aug;11(8):857–62.
16.
Heverhagen JT.
Noise measurement and estimation in MR imaging experiments.
Radiology.
Radiological Society of North America; 2007 Dec;245(3):638–9.
17.
Kaufman L,
Kramer DM,
Crooks LE,
Ortendahl DA.
Measuring signal-to-noise ratios in MR imaging.
Radiology.
1989 Oct;173(1):265–7.